AU2001288604A1 - Guanidinobenzamides as MC4-R agonists - Google Patents

Guanidinobenzamides as MC4-R agonists

Info

Publication number
AU2001288604A1
AU2001288604A1 AU2001288604A AU2001288604A AU2001288604A1 AU 2001288604 A1 AU2001288604 A1 AU 2001288604A1 AU 2001288604 A AU2001288604 A AU 2001288604A AU 2001288604 A AU2001288604 A AU 2001288604A AU 2001288604 A1 AU2001288604 A1 AU 2001288604A1
Authority
AU
Australia
Prior art keywords
guanidinobenzamides
mc4
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001288604A
Other versions
AU2001288604B2 (en
AU2001288604A2 (en
Inventor
Rustum Boyce
Daniel Chu
David Duhl
Kirk Johnson
David Myles
Zhi-Jie Ni
Paul A. Renhowe
Effie Tozzo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Novartis Vaccines And Diagnostic Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US23056500P priority Critical
Priority to US60/230,565 priority
Priority to US60/245,579 priority
Priority to US24557900P priority
Priority to PCT/US2001/027206 priority patent/WO2002018327A2/en
Application filed by Novartis Vaccines And Diagnostic Inc. filed Critical Novartis Vaccines And Diagnostic Inc.
Publication of AU2001288604A1 publication Critical patent/AU2001288604A1/en
Publication of AU2001288604A2 publication Critical patent/AU2001288604A2/en
Application granted granted Critical
Publication of AU2001288604B2 publication Critical patent/AU2001288604B2/en
Assigned to NOVARTIS VACCINES AND DIAGNOSTIC INC. reassignment NOVARTIS VACCINES AND DIAGNOSTIC INC. Request for Assignment Assignors: CHIRON CORPORATION
Application status is Ceased legal-status Critical
Anticipated expiration legal-status Critical

Links

AU2001288604A 2000-08-31 2001-08-31 Guanidinobenzamides as MC4-R agonists Ceased AU2001288604B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US23056500P true 2000-08-31 2000-08-31
US60/230,565 2000-08-31
US24557900P true 2000-11-06 2000-11-06
US60/245,579 2000-11-06
PCT/US2001/027206 WO2002018327A2 (en) 2000-08-31 2001-08-31 Guanidinobenzamides as mc4-r agonists

Publications (3)

Publication Number Publication Date
AU2001288604A1 true AU2001288604A1 (en) 2002-06-06
AU2001288604A2 AU2001288604A2 (en) 2003-05-01
AU2001288604B2 AU2001288604B2 (en) 2005-02-24

Family

ID=26924350

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001288604A Ceased AU2001288604B2 (en) 2000-08-31 2001-08-31 Guanidinobenzamides as MC4-R agonists
AU8860401A Pending AU8860401A (en) 2000-08-31 2001-08-31 Novel guanidinobenzamides

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU8860401A Pending AU8860401A (en) 2000-08-31 2001-08-31 Novel guanidinobenzamides

Country Status (27)

Country Link
US (2) US6638927B2 (en)
EP (1) EP1409468B9 (en)
JP (1) JP4166567B2 (en)
KR (1) KR20030034163A (en)
CN (1) CN1659156A (en)
AP (1) AP200302755A0 (en)
AT (1) AT414067T (en)
AU (2) AU2001288604B2 (en)
BG (1) BG107639A (en)
BR (1) BR0113643A (en)
CA (1) CA2420694C (en)
CZ (1) CZ2003882A3 (en)
DE (1) DE60136571D1 (en)
DZ (1) DZ3415A1 (en)
EA (1) EA200300323A1 (en)
ES (1) ES2316467T3 (en)
HU (1) HU0302067A2 (en)
IL (1) IL154604D0 (en)
MA (1) MA26948A1 (en)
MX (1) MXPA03001813A (en)
NO (1) NO20030929L (en)
NZ (1) NZ524897A (en)
PL (1) PL360698A1 (en)
PT (1) PT1409468E (en)
SI (1) SI21267A (en)
SK (1) SK3832003A3 (en)
WO (1) WO2002018327A2 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716840B2 (en) 2001-04-09 2004-04-06 Chiron Corporation Guanidino compounds
ES2296956T5 (en) * 2001-06-11 2011-07-12 Xenoport, Inc. Gaba analogs, compositions and its uses.
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US20030195187A1 (en) * 2002-02-04 2003-10-16 Chiron Corporation Guanidino compounds
US20030207814A1 (en) * 2002-02-04 2003-11-06 Chiron Corporation Novel guanidinyl derivatives
US20050124652A1 (en) * 2002-02-04 2005-06-09 Rustum Boyce Guanidino compounds
US20030229025A1 (en) * 2002-02-25 2003-12-11 Chiron Corporation Intranasal administration of MC4-R agonists
EP1551834B1 (en) * 2002-05-23 2010-08-25 Novartis Vaccines and Diagnostics, Inc. Substituted quinazolinone compounds
US7125904B2 (en) * 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
CA2508914A1 (en) * 2002-12-04 2004-06-17 Gene Logic Inc. Modulators of melanocortin receptor
EP1608369B1 (en) 2003-03-28 2013-06-26 Novartis Vaccines and Diagnostics, Inc. Use of organic compounds for immunopotentiation
US7625909B2 (en) * 2003-05-23 2009-12-01 Novartis Vaccines And Diagnostics, Inc. Substituted quinazolinone compounds
EP1661898A4 (en) * 2003-08-29 2009-04-15 Takeda Pharmaceutical Bicyclic piperazine compound and use thereof
JP2005306839A (en) * 2003-08-29 2005-11-04 Takeda Chem Ind Ltd Bicyclic piperazine compound and its use
CA2545601A1 (en) * 2003-11-19 2005-06-09 Chiron Corporation Quinazolinone compounds with reduced bioaccumulation
US20080125403A1 (en) 2004-04-02 2008-05-29 Merck & Co., Inc. Method of Treating Men with Metabolic and Anthropometric Disorders
US7618981B2 (en) 2004-05-06 2009-11-17 Cytokinetics, Inc. Imidazopyridinyl-benzamide anti-cancer agents
US7504413B2 (en) 2004-05-06 2009-03-17 Cytokinetics, Inc. N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
US7795448B2 (en) 2004-05-06 2010-09-14 Cytokinetics, Incorporated Imidazoyl-benzamide anti-cancer agents
CN101068538A (en) 2004-11-04 2007-11-07 什诺波特有限公司 Gaba analog prodrug sustained release oral dosage forms
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
US9296697B2 (en) 2005-08-24 2016-03-29 Abbott Laboratories Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-HT5-receptors
SI2348016T1 (en) 2006-06-09 2016-10-28 Synact Pharma Aps Phenyl pyrrole aminoguanidine derivatives
GB0624987D0 (en) 2006-12-14 2007-01-24 Acure Pharma Ab Novel aminoguanidines as melanocortin receptor ligands
TWI389903B (en) 2008-11-12 2013-03-21 Lg Life Sciences Ltd Melanocortin receptor agonists
JP5514831B2 (en) 2008-11-17 2014-06-04 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. Substituted bicyclic amines for the treatment of diabetes
WO2011011506A1 (en) 2009-07-23 2011-01-27 Schering Corporation Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
CA2768577A1 (en) 2009-07-23 2011-01-27 Schering Corporation Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US8476227B2 (en) 2010-01-22 2013-07-02 Ethicon Endo-Surgery, Inc. Methods of activating a melanocortin-4 receptor pathway in obese subjects
US8785634B2 (en) 2010-04-26 2014-07-22 Merck Sharp & Dohme Corp Spiropiperidine prolylcarboxypeptidase inhibitors
WO2011143057A1 (en) 2010-05-11 2011-11-17 Merck Sharp & Dohme Corp. Novel prolylcarboxypeptidase inhibitors
US9006268B2 (en) 2010-06-11 2015-04-14 Merck Sharp & Dohme Corp. Prolylcarboxypeptidase inhibitors
US9018395B2 (en) 2011-01-27 2015-04-28 Université de Montréal Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3177218A (en) * 1962-01-17 1965-04-06 Monsanto Chemicals Methylene-bis(2-guanidino-4-methylquinazoline)
DE2623846A1 (en) * 1976-05-28 1977-12-15 Hoechst Ag 4-quinazolinyl-guanidine and process for their manufacture
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
DE3270716D1 (en) * 1981-02-27 1986-05-28 Ici Plc Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
DE3267110D1 (en) * 1981-05-18 1985-12-05 Ici Plc amidines derivatives
US4921939A (en) * 1985-03-19 1990-05-01 Universite Claude Bernard -Lyon 1 Sweetening agents
JPS6229566A (en) 1985-07-30 1987-02-07 Taiyo Yakuhin Kogyo Kk Novel guanidinomthylbenzoic acid derivative
US4874864A (en) 1988-05-24 1989-10-17 Pfizer Inc. Benzamide protease inhibitors
US4948901A (en) 1988-05-24 1990-08-14 Pfizer Inc. Benzamide protease inhibitors
US4948891A (en) 1988-05-24 1990-08-14 Pfizer Inc. Benzamide protease inhibitors
US5055479A (en) 1988-06-16 1991-10-08 Sankyo Company, Limited Method of treating cachexia
GB8926512D0 (en) 1989-11-23 1990-01-10 Pfizer Ltd Therapeutic agents
CA2032420A1 (en) * 1989-12-22 1991-06-23 Akira Okuyama Guanidinobenzene derivatives
US5124328A (en) 1990-10-11 1992-06-23 Merck & Co., Inc. Morpholine derivatives compositions and use
DE69418601D1 (en) 1993-03-23 1999-06-24 Astra Ab Guanidine derivatives with therapeutic effects
AT231126T (en) 1993-08-12 2003-02-15 Astrazeneca Ab Amidine derivatives with nitrogen oxide synthease activity
US5547966A (en) 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
US5599984A (en) 1994-01-21 1997-02-04 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
US5637439A (en) 1994-11-07 1997-06-10 Mitsubishi Paper Mills Ltd. Photographic silver halide photosensitive material and method for developing the same
AU4534596A (en) 1995-02-09 1996-08-27 Novo Nordisk A/S Compounds with growth hormone releasing properties
DE19544687A1 (en) 1995-11-30 1997-06-05 Thomae Gmbh Dr K Amino acid derivatives, medicaments containing these compounds and processes for their preparation
DE19544685A1 (en) 1995-11-30 1997-06-05 Thomae Gmbh Dr K Amino acid derivatives, medicaments containing these compounds and processes for their preparation
DK0891325T3 (en) 1996-03-29 2002-05-21 Searle & Co Para-substituted phenylpropanoic acid derivatives as integrin antagonists
ZA9703850B (en) 1996-05-06 1997-12-02 Reddy Research Foundation Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US6127343A (en) 1996-05-14 2000-10-03 Novo Nordisk A/S Somatostatin agonists and antagonists
DE69713402T2 (en) 1996-08-23 2002-11-07 Agouron Pharma Ligands of the neuropeptide y
JP2001502712A (en) 1996-10-31 2001-02-27 ノボ ノルディスク アクティーゼルスカブ Constrained somatostatin agonists and antagonists
SK69799A3 (en) * 1996-11-25 2000-06-12 Procter & Gamble Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
WO1997041119A1 (en) 1997-05-02 1997-11-06 Dr. Reddy's Research Foundation Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
AU742425B2 (en) 1998-06-11 2002-01-03 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
DE19831710A1 (en) * 1998-07-15 2000-01-20 Merck Patent Gmbh New diacyl-hydrazine derivatives, are integrin inhibitors useful for treating e.g. thrombosis, cardiac infarction, tumors, osteoporosis, inflammation or infection
FR2784678B1 (en) 1998-09-23 2002-11-29 Sod Conseils Rech Applic New derivatives of N- (iminomethyl) amines, their preparation, their application as medicines and pharmaceutical compositions containing them
EP1156803A4 (en) * 1999-02-09 2004-03-17 Squibb Bristol Myers Co LACTAM INHIBITORS OF FXa AND METHOD
AU766191B2 (en) 1999-06-04 2003-10-09 Merck & Co., Inc. Substituted piperidines as melanocortin-4 receptor agonists
JP2003528810A (en) * 1999-08-04 2003-09-30 ミレニアム ファーマスーティカルズ インク Melanocortin-4 receptor binding compounds and methods of use thereof
GB0002059D0 (en) 2000-01-28 2000-03-22 Melacure Therapeutics Ab Novel aromatic amines
AU2868101A (en) 2000-01-28 2001-08-07 Melacure Therapeutics Ab Novel aromatic amines and amides acting on the melanocortin receptors
JP2003520850A (en) 2000-01-28 2003-07-08 メラキュア セラピューティクス エービー Novel melanocortin receptor agonists and antagonists
JP2003528088A (en) 2000-03-23 2003-09-24 メルク エンド カムパニー インコーポレーテッド Melanocortin receptor operation substituted piperidines such as agonists
US6472398B1 (en) 2000-03-23 2002-10-29 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
GB0102668D0 (en) 2001-02-02 2001-03-21 Glaxo Group Ltd Compounds
US6716840B2 (en) 2001-04-09 2004-04-06 Chiron Corporation Guanidino compounds
EP1551834B1 (en) 2002-05-23 2010-08-25 Novartis Vaccines and Diagnostics, Inc. Substituted quinazolinone compounds

Similar Documents

Publication Publication Date Title
DE60136571D1 (en) Guanidinobenzamides as mc4-r agonists
AU2001253777A1 (en) Antimicrobial composition
AU1416701A (en) Misfet
AU2001240670A1 (en) New aza-indolyl derivatives
AU2001260113A1 (en) 1,2,3,4-tetrahydroisoquinoline derivatives
AU2002220051A1 (en) 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
AU6587000A (en) Composition
AU2001271211A1 (en) Case
AU2001271211A2 (en) Case
AU2002248252A1 (en) Isoindole-imide compounds, compositions, and uses thereof
AU2001260301A1 (en) Novel phenyl-propargylether derivatives
AUPQ713000A0 (en) Kneepad
AU2001282881A1 (en) Real-time sequence determination
AU5919001A (en) Muscarinic agonists
AU2001282615A1 (en) Cathartic composition
AU7432100A (en) Compounds, compositions and use
AU2002359200A1 (en) New composition
AU2001283005A1 (en) Iso-truss structure
AU2001260537A1 (en) 2-aminocarbonyl-9H-purine derivatives
AU6419701A (en) Electropancreatography
AU2001259007A1 (en) Novel composition
AU2001233918A1 (en) Pyridinylimidazoles
AU2001243512A1 (en) Heparinase III and uses thereof
AU6383001A (en) Cache time determination
AU2002246726A1 (en) Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists